MAZE
Maze TherapeuticsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
MAZE vs peer average
40/100
MAZE vs. peer average (D vs. C)
Grade spread
B 1 · C 4 · D 2 · F 1
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
INVA is the first available peer comparator.
Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $1.57B
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
MAZE
Maze Therapeutics
INVA
Innoviva
Grade
D
C
Momentum
40
19
Value
46
71
Sentiment
-
58
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Mixed
Grade position vs INVA
MAZE / INVA
Grade Position
Below peers
MAZE vs. peer average (D vs. C)
40/100
Momentum
40
MAZEValue
46
INVASentiment
-
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs MAZE
INVA is the first peer returned for this comparison set.

